Guardant Health, Inc. (GH): Shareholders' Equity
-$99.31M
As of 2025-12-31
-$222.87M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$99.31M | n/m | 2026-02-19, Balance as of period end |
| 2024-12-31 | -$139.65M | n/m | 2026-02-19, Balance as of period end |
| 2023-12-31 | $158.68M | +163.7% | 2026-02-19, Balance as of period end |
| 2022-12-31 | $60.18M | -90.7% | 2025-02-20, Balance as of period end |
| 2021-12-31 | $645.00M | -50.3% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $1.30B | +62.6% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $798.39M | +65.2% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $483.15M | +56.6% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $308.61M | +287.2% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $79.70M | n/a | 2019-03-19, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | -$99.31M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $577.31M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.31B | +11.4% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $1.36B | +19.6% |
| Natera, Inc. (NTRA) | 2025-12-31 | $1.71B | +43.2% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $303.10M | -19.9% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $563.50M | -58.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $470.87M | +3.3% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.11B | -1.9% |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗